XML 13 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
SubTotal [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2016 $ 50 $ 120,835 $ 67 $ (120,285) $ 667 $ 667
Balance, shares at Dec. 31, 2016 49,782,797            
Net loss (809) (809) (809)
Cumulative effect of adoption of ASC 606 12 (12)
Net unrealized losses on foreign currency translation, net of tax 10 10 10
Issuance of common stock, net of equity issuance costs $ 4 1,175 1,179 1,179
Issuance of common stock, net of equity issuance costs, shares 4,359,994            
Issuance of restricted stock $ 1 1 1
Issuance of restricted stock, shares 750,099            
Restricted stock issued to settle liability 30 30 30
Restricted stock issued to settle liability, shares 67,045            
Exercise of warrants 100 100 100
Exercise of warrants, shares 333,332            
Noncash stock-based compensation 772 772 772
Noncontrolling interest            
Balance at Dec. 31, 2017 $ 55 122,924 77 (121,106) 1,950 1,950
Balance, shares at Dec. 31, 2017 55,293,267            
Net loss (1,429) (1,429) (1,429)
Cumulative effect of adoption of ASC 606 278 278 278
Net unrealized losses on foreign currency translation, net of tax 3 3 3
Issuance of common stock, net of equity issuance costs $ 2 852 854 854
Issuance of common stock, net of equity issuance costs, shares 1,900,000            
Noncash stock-based compensation 242 242 242
Cashless exercise of stock options
Cashless exercise of stock options, shares 22,245            
Cancelled restricted stock shares
Cancelled restricted stock shares, shares (45,859)            
Balance at Mar. 31, 2018 $ 57 124,018 80 (122,257) 1,898 1,898
Balance, shares at Mar. 31, 2018 57,169,653            
Balance at Dec. 31, 2017 $ 55 122,924 77 (121,106) 1,950 1,950
Balance, shares at Dec. 31, 2017 55,293,267            
Net loss (3,325) (3,325) (3,325)
Cumulative effect of adoption of ASC 606 278 278 278
Net unrealized losses on foreign currency translation, net of tax (6) (6) (6)
Issuance of common stock, net of equity issuance costs $ 9 3,769 3,778 3,778
Issuance of common stock, net of equity issuance costs, shares 8,440,669            
Exercise of warrants 138 138 138
Exercise of warrants, shares 456,666            
Noncash stock-based compensation 985 985 985
Noncontrolling interest 3,000 3,000
Cashless exercise of stock options
Cashless exercise of stock options, shares 22,245            
Balance at Dec. 31, 2018 $ 64 127,816 71 (124,153) 3,798 3,000 6,798
Balance, shares at Dec. 31, 2018 64,212,847            
Net loss (1,349) (1,349) (1,349)
Net unrealized losses on foreign currency translation, net of tax (3) (3) (3)
Noncash stock-based compensation 158 158 158
Balance at Mar. 31, 2019 $ 64 $ 127,974 $ 68 $ (125,502) $ 2,604 $ 3,000 $ 5,604
Balance, shares at Mar. 31, 2019 64,212,847